{"id":"https://openalex.org/W32365366","doi":"https://doi.org/10.1002/cpt1971122part1225","title":"The polymorphic acetylation of dapsone in man","display_name":"The polymorphic acetylation of dapsone in man","alternate_titles":[],"publication_year":1971,"publication_date":"1971-03-01","ids":{"openalex":"https://openalex.org/W32365366","doi":"https://doi.org/10.1002/cpt1971122part1225","mag":"32365366","pmid":"https://pubmed.ncbi.nlm.nih.gov/5554939"},"language":"en","primary_location":{"id":"doi:10.1002/cpt1971122part1225","doi":"https://doi.org/10.1002/cpt1971122part1225","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cpt1971122part1225","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W32365366"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015227419","display_name":"ROBERT H. GELBER","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1298353152","display_name":"SRI International","ror":"https://ror.org/05s570m15","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1298353152"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Gelber","raw_affiliation_strings":["The Leprosy Research Unit, Public Health Service Hospital, San Francisco, The Life Sciences Division, Stanford Research Institute, Menlo Park, and the Department of Pharmacology, Division of Medical and Scientific Affairs, Parke, Davis & Co., Ann Arbor, San Francisco and Menlo Park, Calif., and Ann Arbor, Mich","SRI International, Menlo Park, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Leprosy Research Unit, Public Health Service Hospital, San Francisco, The Life Sciences Division, Stanford Research Institute, Menlo Park, and the Department of Pharmacology, Division of Medical and Scientific Affairs, Parke, Davis & Co., Ann Arbor, San Francisco and Menlo Park, Calif., and Ann Arbor, Mich","institution_ids":["https://openalex.org/I1298353152","https://openalex.org/I97018004"]},{"raw_affiliation_string":"SRI International, Menlo Park, United States","institution_ids":["https://openalex.org/I1298353152"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109111451","display_name":"John H. Peters","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1298353152","display_name":"SRI International","ror":"https://ror.org/05s570m15","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1298353152"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John H. Peters","raw_affiliation_strings":["The Leprosy Research Unit, Public Health Service Hospital, San Francisco, The Life Sciences Division, Stanford Research Institute, Menlo Park, and the Department of Pharmacology, Division of Medical and Scientific Affairs, Parke, Davis & Co., Ann Arbor, San Francisco and Menlo Park, Calif., and Ann Arbor, Mich","SRI International, Menlo Park, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Leprosy Research Unit, Public Health Service Hospital, San Francisco, The Life Sciences Division, Stanford Research Institute, Menlo Park, and the Department of Pharmacology, Division of Medical and Scientific Affairs, Parke, Davis & Co., Ann Arbor, San Francisco and Menlo Park, Calif., and Ann Arbor, Mich","institution_ids":["https://openalex.org/I1298353152","https://openalex.org/I97018004"]},{"raw_affiliation_string":"SRI International, Menlo Park, United States","institution_ids":["https://openalex.org/I1298353152"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110218076","display_name":"Gale R. Gordon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1298353152","display_name":"SRI International","ror":"https://ror.org/05s570m15","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1298353152"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Ross Gordon","raw_affiliation_strings":["The Leprosy Research Unit, Public Health Service Hospital, San Francisco, The Life Sciences Division, Stanford Research Institute, Menlo Park, and the Department of Pharmacology, Division of Medical and Scientific Affairs, Parke, Davis & Co., Ann Arbor, San Francisco and Menlo Park, Calif., and Ann Arbor, Mich","SRI International, Menlo Park, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Leprosy Research Unit, Public Health Service Hospital, San Francisco, The Life Sciences Division, Stanford Research Institute, Menlo Park, and the Department of Pharmacology, Division of Medical and Scientific Affairs, Parke, Davis & Co., Ann Arbor, San Francisco and Menlo Park, Calif., and Ann Arbor, Mich","institution_ids":["https://openalex.org/I1298353152","https://openalex.org/I97018004"]},{"raw_affiliation_string":"SRI International, Menlo Park, United States","institution_ids":["https://openalex.org/I1298353152"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060106555","display_name":"Anthony J. Glazko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1298353152","display_name":"SRI International","ror":"https://ror.org/05s570m15","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1298353152"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony J. Glazko","raw_affiliation_strings":["The Leprosy Research Unit, Public Health Service Hospital, San Francisco, The Life Sciences Division, Stanford Research Institute, Menlo Park, and the Department of Pharmacology, Division of Medical and Scientific Affairs, Parke, Davis & Co., Ann Arbor, San Francisco and Menlo Park, Calif., and Ann Arbor, Mich","SRI International, Menlo Park, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Leprosy Research Unit, Public Health Service Hospital, San Francisco, The Life Sciences Division, Stanford Research Institute, Menlo Park, and the Department of Pharmacology, Division of Medical and Scientific Affairs, Parke, Davis & Co., Ann Arbor, San Francisco and Menlo Park, Calif., and Ann Arbor, Mich","institution_ids":["https://openalex.org/I1298353152","https://openalex.org/I97018004"]},{"raw_affiliation_string":"SRI International, Menlo Park, United States","institution_ids":["https://openalex.org/I1298353152"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109527950","display_name":"Louis Levy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1298353152","display_name":"SRI International","ror":"https://ror.org/05s570m15","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1298353152"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Louis Levy","raw_affiliation_strings":["The Leprosy Research Unit, Public Health Service Hospital, San Francisco, The Life Sciences Division, Stanford Research Institute, Menlo Park, and the Department of Pharmacology, Division of Medical and Scientific Affairs, Parke, Davis & Co., Ann Arbor, San Francisco and Menlo Park, Calif., and Ann Arbor, Mich","SRI International, Menlo Park, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Leprosy Research Unit, Public Health Service Hospital, San Francisco, The Life Sciences Division, Stanford Research Institute, Menlo Park, and the Department of Pharmacology, Division of Medical and Scientific Affairs, Parke, Davis & Co., Ann Arbor, San Francisco and Menlo Park, Calif., and Ann Arbor, Mich","institution_ids":["https://openalex.org/I1298353152","https://openalex.org/I97018004"]},{"raw_affiliation_string":"SRI International, Menlo Park, United States","institution_ids":["https://openalex.org/I1298353152"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":5.5073,"has_fulltext":false,"cited_by_count":173,"citation_normalized_percentile":{"value":0.96775819,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"12","issue":"2part1","first_page":"225","last_page":"238"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dapsone","display_name":"dapsone","score":0.9940000176429749},{"id":"https://openalex.org/keywords/acetylation","display_name":"acetylation","score":0.753000020980835},{"id":"https://openalex.org/keywords/genetic-polymorphism","display_name":"genetic polymorphism","score":0.9419999718666077},{"id":"https://openalex.org/keywords/acetylator-phenotype","display_name":"acetylator phenotype","score":0.921999990940094},{"id":"https://openalex.org/keywords/isoniazid","display_name":"isoniazid","score":0.8209999799728394},{"id":"https://openalex.org/keywords/sulfamethazine","display_name":"sulfamethazine","score":0.9929999709129333},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.6240000128746033},{"id":"https://openalex.org/keywords/urinary-excretion","display_name":"urinary excretion","score":0.8059999942779541},{"id":"https://openalex.org/keywords/conjugates","display_name":"conjugates","score":0.5320000052452087},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.6439999938011169}],"concepts":[{"id":"https://openalex.org/C2777640609","wikidata":"https://www.wikidata.org/wiki/Q422226","display_name":"Dapsone","level":2,"score":0.981652557849884},{"id":"https://openalex.org/C119157956","wikidata":"https://www.wikidata.org/wiki/Q796604","display_name":"Acetylation","level":3,"score":0.7354817390441895},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6039092540740967},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.5814527869224548},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.3423495292663574},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33000630140304565},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.24404090642929077},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18780061602592468},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.14129853248596191},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D003622","descriptor_name":"Dapsone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003622","descriptor_name":"Dapsone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003622","descriptor_name":"Dapsone","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003622","descriptor_name":"Dapsone","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007538","descriptor_name":"Isoniazid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007538","descriptor_name":"Isoniazid","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010641","descriptor_name":"Phenotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011110","descriptor_name":"Polymorphism, Genetic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013418","descriptor_name":"Sulfamethazine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013418","descriptor_name":"Sulfamethazine","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/cpt1971122part1225","doi":"https://doi.org/10.1002/cpt1971122part1225","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cpt1971122part1225","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmid:5554939","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/5554939","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2417669623","https://openalex.org/W2411294316","https://openalex.org/W2073192813","https://openalex.org/W2039315235","https://openalex.org/W2398661217","https://openalex.org/W2467023098","https://openalex.org/W2033714857","https://openalex.org/W2037005490","https://openalex.org/W1998164049","https://openalex.org/W2104146111"],"abstract_inverted_index":{"The":[0,49,101],"characteristics":[1],"of":[2,5,13,28,37,40,44,63,67,75,89,98,114,118,120,132,134,140,144,164,200,218],"the":[3,22,26,35,38,41,82,111,126,129,135,141,145,159,201],"acetylation":[4,27,50,106],"dapsone":[6,53,64,69,90,121,124,165,182,214,219,229,232],"(avlosulfon)":[7],"were":[8,84,128,156,220],"found":[9,157,221],"to":[10,46,56,77,207],"parallel":[11],"those":[12],"isoniazid":[14],"and":[15,65,122,153,166,183,215],"sulfamethazine":[16],"in":[17,158,222,233],"19":[18],"subjects,":[19],"thereby":[20],"establishing":[21],"genetic":[23],"polymorphism":[24,31],"for":[25,52,81,194],"dapsone.":[29,100],"This":[30],"was":[32,54,137,204],"revealed":[33],"by":[34,170,210],"distribution":[36],"ratios":[39,74],"plasma":[42,73,127],"concentration":[43],"acetylated":[45,76],"parent":[47,78],"drug.":[48],"capacity":[51],"shown":[55],"be":[57],"a":[58,196],"reproducible,":[59],"individual":[60,83],"characteristic.":[61],"Acetylation":[62],"deacetylation":[66,109],"monoacetyl":[68,99,123,181,228],"occurred":[70],"concurrently.":[71],"Constant":[72],"drug":[79],"characteristic":[80],"attained":[85],"immediately":[86],"after":[87,93,227,231],"administration":[88,97],"but":[91],"only":[92,195],"several":[94],"hours":[95],"following":[96],"available":[102],"data":[103],"suggest":[104],"that":[105],"rather":[107],"than":[108,187,230],"is":[110],"primary":[112],"determinant":[113],"these":[115,191,211],"ratios.":[116],"Rates":[117],"disappearance":[119],"from":[125],"same":[130],"regardless":[131],"which":[133],"two":[136],"administered":[138],"or":[139,172],"acetylator":[142],"phenotype":[143,208],"subject.":[146],"After":[147],"dapsone,":[148],"no":[149],"differences":[150],"between":[151],"rapid":[152],"slow":[154,188],"acetylators":[155,177],"24":[160],"hour":[161,224],"urinary":[162],"excretion":[163],"its":[167,184],"conjugates":[168,186,217],"hydrolyzed":[169],"mild":[171],"strong":[173],"acid":[174],"treatment.":[175],"Rapid":[176],"excreted":[178],"significantly":[179],"more":[180],"acidlabile":[185],"acetylators.":[189],"Because":[190],"compounds":[192],"accounted":[193],"very":[197],"small":[198],"fraction":[199],"dose,":[202],"it":[203],"not":[205],"possible":[206],"individuals":[209],"measurements.":[212],"More":[213],"acid\u2010hydrolyzable":[216],"120":[223],"urine":[225],"collections":[226],"both":[234],"phenotypes.":[235]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W32365366","counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
